Anti-cancer potential of benzophenone-bis-Schiff bases on human pancreatic cancer cell line

Synthetic benzophenone-bis-Schiff bases (1-17) were evaluated for PC3 cell line inhibition. Most of the compounds showed cytotoxic effects but compounds 4, 8, 14, 16, and 17 were found to be potent. The growth inhibition of PC3 cells was in a concentration-dependent manner when treated with compound...

Full description

Bibliographic Details
Published in:Journal of the Chemical Society of Pakistan
Main Author: Khan K.M.; Rasheed H.; Fatima B.; Hayat M.; Rahim F.; Ullah H.; Hameed A.; Taha M.; Tahir A.; Perveen S.
Format: Article
Language:English
Published: Chemical Society of Pakistan 2016
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84995460997&partnerID=40&md5=57fae9b20ad7f8219576edc21143ce65
id 2-s2.0-84995460997
spelling 2-s2.0-84995460997
Khan K.M.; Rasheed H.; Fatima B.; Hayat M.; Rahim F.; Ullah H.; Hameed A.; Taha M.; Tahir A.; Perveen S.
Anti-cancer potential of benzophenone-bis-Schiff bases on human pancreatic cancer cell line
2016
Journal of the Chemical Society of Pakistan
38
5

https://www.scopus.com/inward/record.uri?eid=2-s2.0-84995460997&partnerID=40&md5=57fae9b20ad7f8219576edc21143ce65
Synthetic benzophenone-bis-Schiff bases (1-17) were evaluated for PC3 cell line inhibition. Most of the compounds showed cytotoxic effects but compounds 4, 8, 14, 16, and 17 were found to be potent. The growth inhibition of PC3 cells was in a concentration-dependent manner when treated with compounds 4, 8, 14, 16 and 17 (Figure-2) after 24 h exposure time. The IC50 values of all five most active compounds were calculated as 4 (IC50 = 24 ± 1.4 μM), 8 (IC50 = 29 ± 1.3 μM), 14 (IC50 = 66 ± 2.8 μM), 16 (IC50 = 28 ± 1.4 μM) and 17 (IC50 = 18 ± 2.8 μM) when compared with standard cisplatin (IC50 = 20 ± 1.1 μM). This study has identified potent anticancer agents. © 2016, Chemical Society of Pakistan. All rights reserved.
Chemical Society of Pakistan
2535106
English
Article

author Khan K.M.; Rasheed H.; Fatima B.; Hayat M.; Rahim F.; Ullah H.; Hameed A.; Taha M.; Tahir A.; Perveen S.
spellingShingle Khan K.M.; Rasheed H.; Fatima B.; Hayat M.; Rahim F.; Ullah H.; Hameed A.; Taha M.; Tahir A.; Perveen S.
Anti-cancer potential of benzophenone-bis-Schiff bases on human pancreatic cancer cell line
author_facet Khan K.M.; Rasheed H.; Fatima B.; Hayat M.; Rahim F.; Ullah H.; Hameed A.; Taha M.; Tahir A.; Perveen S.
author_sort Khan K.M.; Rasheed H.; Fatima B.; Hayat M.; Rahim F.; Ullah H.; Hameed A.; Taha M.; Tahir A.; Perveen S.
title Anti-cancer potential of benzophenone-bis-Schiff bases on human pancreatic cancer cell line
title_short Anti-cancer potential of benzophenone-bis-Schiff bases on human pancreatic cancer cell line
title_full Anti-cancer potential of benzophenone-bis-Schiff bases on human pancreatic cancer cell line
title_fullStr Anti-cancer potential of benzophenone-bis-Schiff bases on human pancreatic cancer cell line
title_full_unstemmed Anti-cancer potential of benzophenone-bis-Schiff bases on human pancreatic cancer cell line
title_sort Anti-cancer potential of benzophenone-bis-Schiff bases on human pancreatic cancer cell line
publishDate 2016
container_title Journal of the Chemical Society of Pakistan
container_volume 38
container_issue 5
doi_str_mv
url https://www.scopus.com/inward/record.uri?eid=2-s2.0-84995460997&partnerID=40&md5=57fae9b20ad7f8219576edc21143ce65
description Synthetic benzophenone-bis-Schiff bases (1-17) were evaluated for PC3 cell line inhibition. Most of the compounds showed cytotoxic effects but compounds 4, 8, 14, 16, and 17 were found to be potent. The growth inhibition of PC3 cells was in a concentration-dependent manner when treated with compounds 4, 8, 14, 16 and 17 (Figure-2) after 24 h exposure time. The IC50 values of all five most active compounds were calculated as 4 (IC50 = 24 ± 1.4 μM), 8 (IC50 = 29 ± 1.3 μM), 14 (IC50 = 66 ± 2.8 μM), 16 (IC50 = 28 ± 1.4 μM) and 17 (IC50 = 18 ± 2.8 μM) when compared with standard cisplatin (IC50 = 20 ± 1.1 μM). This study has identified potent anticancer agents. © 2016, Chemical Society of Pakistan. All rights reserved.
publisher Chemical Society of Pakistan
issn 2535106
language English
format Article
accesstype
record_format scopus
collection Scopus
_version_ 1809678487336779776